Neil Blumenthal - Warby Parker Co-Founder, Director
| WRBY Stock | USD 24.58 1.64 6.25% |
Insider
Neil Blumenthal is Co-Founder, Director of Warby Parker since 2018.
| Age | 44 |
| Tenure | 7 years |
| Address | 233 Spring Street, New York, NY, United States, 10013 |
| Phone | 646 847 7215 |
| Web | https://www.warbyparker.com |
Neil Blumenthal Latest Insider Activity
Tracking and analyzing the buying and selling activities of Neil Blumenthal against Warby Parker stock is an integral part of due diligence when investing in Warby Parker. Neil Blumenthal insider activity provides valuable insight into whether Warby Parker is net buyers or sellers over its current business cycle. Note, Warby Parker insiders must abide by specific rules, including filing SEC forms every time they buy or sell Warby Parker'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Neil Blumenthal over three weeks ago Acquisition by Neil Blumenthal of 26582 shares of Warby Parker subject to Rule 16b-3 | ||
Neil Blumenthal over a month ago Disposition of 50000 shares by Neil Blumenthal of Warby Parker at 23.65 subject to Rule 16b-3 | ||
Neil Blumenthal over three months ago Disposition of 462 shares by Neil Blumenthal of Warby Parker at 14.16 subject to Rule 16b-3 | ||
Neil Blumenthal over six months ago Acquisition by Neil Blumenthal of 5016 shares of Warby Parker subject to Rule 16b-3 |
Warby Parker Management Efficiency
The company has return on total asset (ROA) of (0.0422) % which means that it has lost $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1015) %, meaning that it created substantial loss on money invested by shareholders. Warby Parker's management efficiency ratios could be used to measure how well Warby Parker manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.11 in 2025. Return On Capital Employed is likely to drop to -0.19 in 2025. At this time, Warby Parker's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 10.3 M in 2025, whereas Total Assets are likely to drop slightly above 486.3 M in 2025.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mischa Reis | Envista Holdings Corp | 53 | |
| Samrat Esq | Becton Dickinson and | 57 | |
| Michael Onuscheck | Alcon AG | 53 | |
| Richard Luzzi | West Pharmaceutical Services | 72 | |
| Scott Huennekens | Envista Holdings Corp | 55 | |
| Matthew DellaMaria | AptarGroup | N/A | |
| Kevin Thornal | Hologic | 50 | |
| Ines Poeschel | Alcon AG | 52 | |
| R Eckert | Becton Dickinson and | 59 | |
| Kimberly Chainey | AptarGroup | 49 | |
| Gayle Sheppard | Envista Holdings Corp | 66 | |
| JeanClaude Kyrillos | Envista Holdings Corp | 60 | |
| Constance Bienfait | ResMed Inc | N/A | |
| Neil Peterson | Merit Medical Systems | 58 | |
| Paul Malenchini | Hologic | N/A | |
| John CFA | Teleflex Incorporated | N/A | |
| Kimberly MacKay | West Pharmaceutical Services | 59 | |
| A Bender | The Cooper Companies, | 79 | |
| Heidi Tlili | AptarGroup | 49 | |
| Ching leong | Becton Dickinson and | 53 | |
| Vivek Jain | Envista Holdings Corp | 60 | |
Management Performance
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0422 |
Warby Parker Leadership Team
Elected by the shareholders, the Warby Parker's board of directors comprises two types of representatives: Warby Parker inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Warby. The board's role is to monitor Warby Parker's management team and ensure that shareholders' interests are well served. Warby Parker's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Warby Parker's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kim Nemser, SVP Officer | ||
| Tina Romani, VP Relations | ||
| Sandy Gilsenan, SVP Officer | ||
| Lori Krauss, Senior Officer | ||
| Andrew Hunt, CoFounder Director | ||
| Steve Miller, VP CFO | ||
| Stephanie Hart, VP Operations | ||
| Chris Utecht, General VP | ||
| Lee Fixel, Director | ||
| Neil Blumenthal, Co-Founder, Director | ||
| Jeff Raider, CoFounder Director | ||
| David Gilboa, Co-Founder, Director | ||
| Jeffrey Saunders, Senior CTO | ||
| Jeffrey Raider, Director | ||
| Jaclyn Berkley, Head Relations | ||
| Chelsea Kaden, Senior Officer | ||
| Hyung Bak, Gen VP |
Warby Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Warby Parker a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0422 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.1 B | ||||
| Shares Outstanding | 101.66 M | ||||
| Shares Owned By Insiders | 7.10 % | ||||
| Shares Owned By Institutions | 98.86 % | ||||
| Number Of Shares Shorted | 11.18 M | ||||
| Price To Book | 9.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Warby Stock Analysis
When running Warby Parker's price analysis, check to measure Warby Parker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Warby Parker is operating at the current time. Most of Warby Parker's value examination focuses on studying past and present price action to predict the probability of Warby Parker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Warby Parker's price. Additionally, you may evaluate how the addition of Warby Parker to your portfolios can decrease your overall portfolio volatility.